Source: NORTH CAROLINA HEALTH NEWS, 8/23/21


At sunrise, when the North Carolina sky slowly wakes up to light blue, Kevin Saunders gets into his white coat and is ready to dive into his research. As a director of research at the Duke Human Vaccine Institute, Saunders studies the human immunodeficiency virus (HIV) with hopes of discovering a vaccine that could prevent transmission of the virus and the disease that goes along with it. Then COVID-19 came along, and his vaccine research took a sharp detour. “Since the pandemic, we started to work more on coronavirus,” Saunders said in an interview at the end of June. “We had to learn about it and to build all of the vaccine tools.”

For more of this story, click here.